Is HC Wainwright & Co. a reliable analyst?

In short — Over 1 year, 56.9% of HC Wainwright & Co.'s targets proved profitable, for an average gain of +22.5% per call (all calls, winners and losers) — i.e. +15.1% vs its sector, across 65 timestamped calls replayed against real prices. JPI verdict: fairly reliable. An analyst can be good in one sector and poor in another — details below.

56.9%profitable calls

+22.5%avg gain / call

+15.1%vs sector

65scored calls

In which sectors is HC Wainwright & Co. reliable?

Sector

Calls

% profitable

Avg gain 2015+

Avg gain 2020+

Last 12 months

▸ Finance

64.3%

+83.5%

-0.9% (6)

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
COIN	▲ Buy	May 8, 26	May 8, 27	$216.6	🎯$310	$163.51	+43%	-25% so far
COIN	▲ Buy	Feb 11, 26	Feb 11, 27	$141.09	🎯$350	$163.51	+148%	+16% so far
COIN	▲ Buy	Oct 31, 25	Oct 31, 26	$343.78	🎯$425	$163.51	+24%	-52% so far
COIN	▲ Buy	Oct 30, 25	Oct 30, 26	$328.51	🎯$425	$163.51	+29%	-50% so far
COIN	▼ Sell	Aug 1, 25	Aug 1, 26	$314.69	🎯$300	$163.51	-5%	-48% so far
COIN	▼ Sell	Jul 10, 25	Jul 10, 26	$388.96	🎯$300	$163.51	-23%	-58% so far
COIN	▲ Buy	Feb 24, 25	Feb 24, 26	$227.07	🎯$350	$161.22	+54%	-28.6%
COIN	▲ Buy	Feb 21, 25	Feb 21, 26	$227.07	🎯$350	$161.22	+54%	-29.4%

Sample (2 recent finished + 6 in progress) of 14 calls.

▸ Health

54.9%

+5.8%

+7.3%

+18.9% (18)

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
INCY	▲ Buy	Jun 29, 26	Jun 29, 27	$114.66	🎯$140	$118.05	+22%	+3% so far
INCY	▲ Buy	Jun 24, 26	Jun 24, 27	$108.46	🎯$140	$118.05	+29%	+9% so far
INCY	▲ Buy	Jun 9, 26	Jun 9, 27	$105.39	🎯$140	$118.05	+33%	+12% so far
INCY	▲ Buy	May 21, 26	May 21, 27	$97.41	🎯$135	$118.05	+39%	+21% so far
INCY	▲ Buy	May 4, 26	May 4, 27	$97.14	🎯$135	$118.05	+39%	+22% so far
INCY	▲ Buy	Apr 15, 26	Apr 15, 27	$97.1	🎯$135	$118.05	+39%	+22% so far
BIIB	▲ Buy	Apr 2, 26	Apr 2, 27	$177.34	🎯$237	$205.7	+34%	+16% so far
INCY	▲ Buy	Mar 30, 26	Mar 30, 27	$90.33	🎯$135	$118.05	+49%	+31% so far

Sample (0 recent finished + 8 in progress) of 51 calls.

The stocks HC Wainwright & Co. covers (track record per stock)

Stock

Calls

% profitable

Avg gain 2015+

Avg gain 2020+

Last 12 months

▸ COIN Coinbase

64.3%

+83.5%

-0.9% (6)

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
COIN	▲ Buy	May 8, 26	May 8, 27	$216.6	🎯$310	$163.51	+43%	-25% so far
COIN	▲ Buy	Feb 11, 26	Feb 11, 27	$141.09	🎯$350	$163.51	+148%	+16% so far
COIN	▲ Buy	Oct 31, 25	Oct 31, 26	$343.78	🎯$425	$163.51	+24%	-52% so far
COIN	▲ Buy	Oct 30, 25	Oct 30, 26	$328.51	🎯$425	$163.51	+29%	-50% so far
COIN	▼ Sell	Aug 1, 25	Aug 1, 26	$314.69	🎯$300	$163.51	-5%	-48% so far
COIN	▼ Sell	Jul 10, 25	Jul 10, 26	$388.96	🎯$300	$163.51	-23%	-58% so far
COIN	▲ Buy	Feb 24, 25	Feb 24, 26	$227.07	🎯$350	$161.22	+54%	-28.6%
COIN	▲ Buy	Feb 21, 25	Feb 21, 26	$227.07	🎯$350	$161.22	+54%	-29.4%

Sample (2 recent finished + 6 in progress) of 14 calls.

▸ VRTX Vertex Pharmaceuticals

76%

+15.3%

+17.7%

+14.9% (4)

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
VRTX	▲ Buy	Mar 10, 26	Mar 10, 27	$499.17	🎯$641	$522.25	+28%	+5% so far
VRTX	▲ Buy	Feb 17, 26	Feb 17, 27	$477.32	🎯$591	$522.25	+24%	+9% so far
VRTX	▲ Buy	Feb 13, 26	Feb 13, 27	$491.47	🎯$518	$522.25	+5%	+6% so far
VRTX	▲ Buy	Aug 5, 25	Aug 5, 26	$374.98	🎯$478	$522.25	+27%	+39% so far
VRTX	▲ Buy	Jun 23, 25	Jun 23, 26	$443.54	🎯$550	$470.15	+24%	+5.6%
VRTX	▲ Buy	Feb 11, 25	Feb 11, 26	$455.22	🎯$550	$459.77	+21%	+1.3%
VRTX	▲ Buy	Jan 31, 25	Jan 31, 26	$461.68	🎯$550	$470.91	+19%	+2.2%
VRTX	▲ Buy	Dec 20, 24	Dec 20, 25	$397.27	🎯$535	$460.83	+35%	+15.9%

Sample (4 recent finished + 4 in progress) of 25 calls.

▸ REGN Regeneron Pharmaceuticals

80%

+13.6%

—

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
REGN	▲ Buy	Nov 5, 21	Nov 5, 22	$611.54	🎯$844	$752.19	+38%	+22.8%
REGN	▲ Buy	Oct 22, 21	Oct 22, 22	$576.2	🎯$842	$737.54	+46%	+27.9%
REGN	▲ Buy	Sep 15, 21	Sep 15, 22	$652	🎯$831	$704.16	+27%	+8.3%
REGN	▲ Buy	Aug 2, 21	Aug 2, 22	$577.13	🎯$741	$577.13	+28%	-0.4%
REGN	▲ Buy	Jun 29, 21	Jun 29, 22	$545.98	🎯$703	$595.12	+29%	+9.5%

▸ BIIB Biogen

23.8%

-7.3%

-7.7%

+26.0% (3)

Stock	Rating	Issued	Matures (1yr)	Price at call	Target	End price	Targeted	Result
BIIB	▲ Buy	Apr 2, 26	Apr 2, 27	$177.34	🎯$237	$205.7	+34%	+16% so far
BIIB	▲ Buy	Feb 9, 26	Feb 9, 27	$193.81	🎯$228	$205.7	+18%	+6% so far
BIIB	▲ Buy	Aug 1, 25	Aug 1, 26	$131.95	🎯$194	$205.7	+47%	+56% so far
BIIB	▲ Buy	Jun 26, 25	Jun 26, 26	$126.92	🎯$187	$215.76	+47%	+70.2%
BIIB	▲ Buy	May 2, 25	May 2, 26	$123.53	🎯$187	$187.77	+51%	+51.6%
BIIB	▲ Buy	Feb 13, 25	Feb 13, 26	$138.45	🎯$241	$196.6	+74%	+41.9%
BIIB	▲ Buy	Oct 31, 24	Oct 31, 25	$173.79	🎯$300	$151.2	+73%	-12.9%
BIIB	▲ Buy	May 23, 24	May 23, 25	$218.06	🎯$300	$126.47	+38%	-42.3%

Sample (5 recent finished + 3 in progress) of 21 calls.

% profitable = share of its calls that made money (1 year). Avg gain / call = average absolute gain per call (winners and losers). Point-in-time, S&P 500 backtest.